The diagnosis of growth hormone (GH) deficiency (GHD) in childhood is not straightforward, being still based on a comprehensive clinical, anthropometric, endocrine and neuroradiological assessment. Due to their GH dependency and relative stability in circulation, IGF-I and IGFBP-3 serum concentrations were proposed as reliable indicators of daily GH secretion. However, the sensitivity of assays for both IGF-I and IGFBP-3 is inadequate to exclude the diagnosis of GHD merely on the basis of a normal value of the two parameters, although it seems likely that IGF-I values higher than -1 SD reflect a normal GH secretion. On the other hand, as the specificity of both measurements is over 90%, subnormal concentrations strongly support the diagnosis of GHD. Finally, combining the evaluation of growth velocity with IGF-I measurement, sensitivity and specificity reach a value >= 95%, implying that two subnormal values strongly suggest and two normal values strongly oppose the diagnosis of GHD

Cianfarani, S., Liguori, A., Germani, D. (2005). IGF-I and IGFBP-3 assessment in the management of childhood onset growth hormone deficiency. In S. Cianfarani, D.R. Clemmons, M.O. Savage (a cura di), Igf-i and Igf binding proteins: basic research and clinical management (pp. 66-75). Karger [10.1159/000085757].

IGF-I and IGFBP-3 assessment in the management of childhood onset growth hormone deficiency

CIANFARANI, STEFANO;GERMANI, DANIELA
2005-01-01

Abstract

The diagnosis of growth hormone (GH) deficiency (GHD) in childhood is not straightforward, being still based on a comprehensive clinical, anthropometric, endocrine and neuroradiological assessment. Due to their GH dependency and relative stability in circulation, IGF-I and IGFBP-3 serum concentrations were proposed as reliable indicators of daily GH secretion. However, the sensitivity of assays for both IGF-I and IGFBP-3 is inadequate to exclude the diagnosis of GHD merely on the basis of a normal value of the two parameters, although it seems likely that IGF-I values higher than -1 SD reflect a normal GH secretion. On the other hand, as the specificity of both measurements is over 90%, subnormal concentrations strongly support the diagnosis of GHD. Finally, combining the evaluation of growth velocity with IGF-I measurement, sensitivity and specificity reach a value >= 95%, implying that two subnormal values strongly suggest and two normal values strongly oppose the diagnosis of GHD
2005
Settore MED/13 - ENDOCRINOLOGIA
Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA
English
Rilevanza internazionale
Capitolo o saggio
biological marker; human growth hormone; somatomedin binding protein 3; somatomedin C; blood; child; growth disorder; human; metabolism; review; human growth hormone; insulin-like growth factor binding protein 3; insulin-like growth factor I
Cianfarani, S., Liguori, A., Germani, D. (2005). IGF-I and IGFBP-3 assessment in the management of childhood onset growth hormone deficiency. In S. Cianfarani, D.R. Clemmons, M.O. Savage (a cura di), Igf-i and Igf binding proteins: basic research and clinical management (pp. 66-75). Karger [10.1159/000085757].
Cianfarani, S; Liguori, A; Germani, D
Contributo in libro
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/62387
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 18
social impact